Capabilities to transfer
Workflows, expertise and systems designed around your local institution.
- mNGS for unexplained infection
- Broad-range pathogen detection.
- Targeted pathogen panels
- Syndromic and organism-specific.
- Antimicrobial resistance profiling
- Genotypic resistance prediction.
- Outbreak surveillance
- Genomic epidemiology workflows.
- 16S and shotgun metagenomics
- Microbiome community profiling.
- Bioinformatics pipelines
- Local deployment and validation.
What does your institution need first?
Begin with your existing infrastructure, clinical governance and local regulatory pathway. Feasibility establishes the programme requirements.
Discussion preparation
Your institutional baseline
Use these prerequisites to prepare a discussion. This checklist is not a clinical assessment or a determination of regulatory readiness.
0 of 3discussion prerequisites identified.
Explore related partner services.
Read each service’s complete scope and regulatory note. These links help you explore the portfolio; programme-specific suitability requires feasibility assessment.
One sequencing capability, distinct use cases.
Infectious-disease investigation, public-health surveillance and microbiome research ask different questions of a sequencing laboratory. Agree the use case before setting the assay menu or reporting scope. A shared technical foundation still needs separate acceptance criteria and interpretation arrangements for each programme.
CDC’s NGS Quality Initiative provides a sequencing-focused quality-management framework for clinical and public-health laboratories. Its resources address the system around a test, as well as the testing workflow.
CDC: The Next Generation Sequencing Quality InitiativeThe international microbiome-testing consensus identifies limited evidence for clinical usefulness and calls for clear indications, validated methods and transparent reporting. A descriptive microbiome profile should be distinguished from a proven clinical decision tool.
Porcari and colleagues · The Lancet Gastroenterology & Hepatology: International consensus statement on microbiome testing in clinical practiceExternal references explain the wider context. They do not verify or endorse the supplied VectorGene or partner offering.
Questions for the programme brief
Investigation, surveillance or research?
Specify who needs the result, how quickly it is needed and which action or research question it will support.
Which analytical scope?
Review specimen types, controls, reference databases and the limits of detection and interpretation to be evaluated.
Which reporting pathway?
Agree specialist review, public-health escalation or research reporting, with clear responsibilities for uncertain findings.
What to prepare for review
- Use cases and specimen volumes
- Existing microbiology and sequencing workflow
- Report recipients and escalation requirements
Working environments
Tools for microbial research.
Illustrative stock photography provides context for the people, processes and working environments behind this capability.
Each vial highlights one planning question. The drawing is an illustrative object.
- Sample
- What collection and handling requirements apply?
- Method
- Which organisms and reference databases are in scope?
- Interpretation
- How will findings support research or a clinical decision?
